Raaj Trivedi, BioClinica's VP Commercial Operations, just received 17,500 options from the company. The strike price of the options received was $1.34, and these expire on February 28, 2026. Trivedi now owns at least 17,500 options on the company.
Some additional info was provided as follows:
25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/29/16) with the balance vesting in equal monthly installments thereafter until fully vested on February 29, 2020.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To re ceive a free e-mail notification whenever BioClinica makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Announces Pricing Of Public Offering Of Up To 4,925,936 Shares Of Common Stock - Dec. 6, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 6, 2017
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Dec. 6, 2017
General form for registration of securities under the Securities Act of 1933 - Nov. 21, 2017